With declining demand, the Ministry of Health and Anvisa enhance the safety of the dengue vaccine National newspaper

Hey Ministry of Health Collected, this Friday (8), pathologists and Anfisa To confirm the safety of the dengue vaccine.

Shoulder pain when taking the injection. For the vast majority of people who have already had the dengue vaccine, this was the only reaction.

As of the fourth of this month, 365,610 doses have been administered in public and private networks. In the Unified Health System for children aged 10-11 years – before the population increases to 14 years. In clinics, for people up to 59 years old.

The Ministry of Health received only 529 reports in which 70 people had hypersensitivity reactions to the vaccine, such as topical reactions; 16 cases of allergic reactions were considered serious. With three anaphylactic shocks, the most serious. There have been hospitalizations, and everyone has already been discharged. And without any deaths.

In the opinion of the Ministry of Health, the cases are few, which enhances the safety of the vaccine.

“For the Ministry of Health, the vaccine is considered safe and effective. So, the strategy is to continue vaccination. The pharmacovigilance system will continue to analyze the data and obviously we will continue our monitoring,” says Eder Gatti, director of the department. From the National Immunization Program (PNI).

The vaccine manufacturer, Takeda Laboratory, did not record the possibility of anaphylactic shock in clinical studies. Anvisa, the National Health Surveillance Agency, which approved the use of the vaccine, specified the change in the bulletin within 30 days, but highlighted that the recorded cases are rare.

“We emphasize that the occurrence of these events remains rare and that the benefits of vaccination outweigh the risks posed by dengue,” says Cascia. “It is important to highlight that all reported cases, as we said previously, have been treated, and the patients have recovered.” Di Fatima, Director of Anvisa.

Experts praised the ministry's transparency.

“This is an assurance to the population that the vaccine remains safe and that the Ministry of Health is acting in an exemplary manner in investigating and monitoring these events,” comments infectious disease specialist Giulio Croda.

Health Minister Nicia Trindade also confirmed that the vaccine is one of the measures to prevent dengue fever and that all of the ministry’s measures are based on scientific standards.

“The entire line of work of the Ministry of Health is based not only on science, but science is the guarantee of access, the guarantee of quality, and that is why we have been talking about quality care in Brazil and vaccination is part of that.” Care,” says the minister.

Controlling dengue mosquito outbreaks is essential, and another precautionary measure that remains a priority is the use of repellents.